Decreased expression of NDRG2 is related to poor overall survival in patients with glioma

Journal of Clinical Neuroscience

Volumn 18, Issue 11, 2011, Pages 1534-1537

  Li, Wei ^a   Chu, Dake ^b   Chu, Xiaodan ^a   Meng, Fanhua ^a   Wei, Dun ^a   Li, Haiping ^a   Sun, Boqian ^a  

^a BEIHUA UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Immunohistochemistry; NDRG2; Survival

Indexed keywords

MYC PROTEIN; N MYC DOWNSTREAM REGULATED GENE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 80053569863     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.12.032     Document Type: Article

References (25)

1. P. Kleihues, P.C. Burger, and B.W. Scheithauer The new WHO classification of brain tumours Brain Pathol 3 1993 255 268 (Pubitemid 23276692)
2. H. Wakimoto, M. Aoyagi, and T. Nakayama Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas Cancer 77 1996 373 380 (Pubitemid 26025528)
3. I.F. Pollack Current concepts in the diagnosis and treatment of pediatric brain tumors N Engl J Med 331 1994 1500 1507
4. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
5. M.S. Mahaley Jr., C. Mettlin, and N. Natarajan National survey of patterns of care for brain-tumor patients J Neurosurg 71 1989 826 836 (Pubitemid 20008561)
6. M.D. Walker, S.B. Green, and D.P. Byar Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 1980 1323 1329 (Pubitemid 11194457)
7. H. Ohgaki, and P. Kleihues Epidemiology and etiology of gliomas Acta Neuropathol 109 2005 93 108 (Pubitemid 40287792)
8. A. Shimono, T. Okuda, and H. Kondoh N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant Mech Dev 83 1999 39 52 (Pubitemid 29302080)
9. T. Okuda, and H. Kondoh Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc Biochem Biophys Res Commun 266 1999 208 215 (Pubitemid 30028793)
10. N. van Belzen, W.N. Dinjens, and M.P. Diesveld A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms Lab Invest 77 1997 85 92 (Pubitemid 27328362)
11. X. Qu, Y. Zhai, and H. Wei Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family Mol Cell Biochem 229 2002 35 44 (Pubitemid 34187673)
12. R.H. Zhou, K. Kokame, and Y. Tsukamoto Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart Genomics 73 2001 86 97 (Pubitemid 32382390)
13. N. Liu, L. Wang, and X. Li N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis Nucleic Acids Res 36 2008 5335 5349
14. Y.J. Kim, S.Y. Yoon, and J.T. Kim NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells Int J Cancer 124 2009 7 15
15. E.A. Lusis, M.A. Watson, and M.R. Chicoine Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma Cancer Res 65 2005 16
16. A. Lorentzen, L.K. Vogel, and R.H. Lewinsky Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma BMC Cancer 7 2007 192 200
17. H. Furuta, Y. Kondo, and S. Nakahata NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma Biochem Biophys Res Commun 391 2010 1785 1791
18. M.P. Tschan, D. Shan, and J. Laedrach NDRG1/2 expression is inhibited in primary acute myeloid leukemia Leuk Res 34 2010 393 398
19. D.K. Chu, J. Zhang, and H. Shi Expression of candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colon cancer Zhonghua Wei Chang Wai Ke Za Zhi 11 2008 354 357
20. M. Tepel, P. Roerig, and M. Wolter Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma Int J Cancer 123 2008 2080 2086
21. B. Sun, D. Chu, and W. Li Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients J Neurooncol 94 2009 213 219
22. R.S. Brown, and R.L. Wahl Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study Cancer 72 1993 2979 2985 (Pubitemid 23335044)
23. S.S. Stylli, M. Howes, and L. MacGregor Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome J Clin Neurosci 11 2004 584 596 (Pubitemid 38916966)
24. S.S. Stylli, A.H. Kaye, and L. MacGregor Photodynamic therapy of high grade glioma-long term survival J Clin Neurosci 12 2005 389 398 (Pubitemid 40745222)
25. S.S. Stylli, and A.H. Kaye Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies J Clin Neurosci 13 2006 709 717 (Pubitemid 44354170)